#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Subdural haematoma Glomerulonephritis membranous Nephroblastoma Granulomatosis with polyangiitis Netherton's syndrome Gastric cancer Fontan procedure Blastic plasmacytoid dendritic cell neoplasia Pemphigus Encephalopathy neonatal Progressive familial intrahepatic cholestasis Antisynthetase syndrome Factor VIII deficiency Wolfram syndrome Lip and/or oral cavity cancer More trials…

    Learn about Rare Diseases

    Splenic marginal zone lymphoma – Diagnostics Mucopolysaccharidosis II – Diagnostics Haemophilia B with anti factor IX – Life with Disease Prolymphocytic leukaemia – Life with Disease Turner’s syndrome Niemann-Pick disease – Trials in Disease Atypical haemolytic uraemic syndrome Lysosomal storage disorder Cytokine release syndrome – Life with Disease Basal cell naevus syndrome – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Apl-101 Bt-001 Heterodimeric Interleukin-15 Rbd1016 Davutamig Bi-1910 Oteracil Brivaracetam Phenol Testosterone Undecanoate BUMETANIDE Vibozilimod Tipranavir Emraclidine Piperacillin Sodium Citalopram Hydrobromide Cimetidine Hydrochloride Ttx-030 AMG 732 Bms-986458 More therapies…

    Learn about Your Condition

    Cardiac failure Diffuse large B-cell lymphoma Sarcoma Acute HIV infection Cardiac failure congestive Haemorrhage prophylaxis Oxygen therapy Apathy Partial seizures Migraine Ovarian cancer recurrent Carotid artery occlusion Lower limb fracture Tardive dyskinesia Small fibre neuropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Osteochondrodysplasia

  • Study on the Effects of TransCon CNP in Children Aged 2-11 with Achondroplasia

    Not recruiting

    2 1
    Investigated Drugs:
    • C-Type Natriuretic Peptide Conjugated To A Multi-Arm Polyethylene Glycol Carrier Molecule Through A Cleavable Linker
    Denmark Ireland Spain

  • Study on the Effectiveness and Safety of Infigratinib for Children Aged 3 to 17 with Achondroplasia

    Not recruiting

    3 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Infigratinib
    France Germany Italy Norway Spain

  • Study on the Effects of Navepegritide and Lonapegsomatropin in Children with Achondroplasia

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Lonapegsomatropin
    Denmark Ireland

  • Study on Long-Term Safety and Effects of Vosoritide in Children with Achondroplasia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Vosoritide
    France

  • Study on the Safety and Effects of SAR442501 for Children with Achondroplasia

    Not recruiting

    2 1 1
    Czechia Italy Spain

  • Study on the Long-Term Safety and Effectiveness of Vosoritide for Children with Achondroplasia

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteochondrodysplasia
    Investigated Drugs:
    • Vosoritide
    Germany Spain
Previous Page
1 2

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!